Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Significant Tender Win

28 Jul 2021 09:12

RNS Number : 7493G
Directa Plus PLC
28 July 2021
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (596/2014) WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

28 July 2021

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Significant Further Tender Win from OMV Petrom

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that it has won an additional tender from OMV Petrom, the largest oil and gas group in south-eastern Europe, for the provision of waste treatment services utilising the Company's Grafysorber® and the supply of related products. The four-year contract has a total value of €3,200,000, with an invoice value of approximately €800,000 per annum, and is expected to commence in August 2021.

 

OMV's objectives are to improve the oil production process in one of the company's upstream production assets in Romania and to contain production costs by applying the most effective technology solution to the treatment of produced water and sludges while preventing oil spills and providing remediation services. It is expected that approximately 80,000 cubic meters of sludge and waste produced during the first upstream separation process will be treated over the four year contract period and that up to 20,000 tons of crude oil with impurities below 1% will be recovered and sent to the refinery.

 

In addition, it is expected that some 50,000 cubic meters of produced water will be treated over the same period using dedicated engineering equipment, increasing water injection quality while meeting national regulations to minimise the use of water resources. Directa Plus will supply a total of 700 highly-performant adsorbent devices containing Grafysorber® to OMV Petrom to insulate, clean and eliminate any accidental oil spills during the workover and intervention operations, mitigating any environmental impact.

 

Directa Plus's patented Grafysorber® technology is a graphene-based solution for treating water sludges and emulsions containing hydrocarbons and is at least five times more effective than current technologies - adsorbing more than 100 times its own weight of oil-based pollutants. In addition, Grafysorber® is sustainably produced, non-flammable and reusable, with the adsorbed hydrocarbons recoverable.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This is our second major contract from OMV Petrom. Repeat business demonstrates a satisfied customer which has already seen our technology and services successfully applied to their operations.

 

"With the recent trend of the oil price, we expect more E&P companies will find our oil recovery services attractive. Grafysorber® is continuing to gain traction with and generate interest from the international oil and gas industry that require an environmentally friendly solution to treat produced water and sludges."

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

For further information please visit www.directa-plus.com or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

Giorgio Bonfanti, CFO

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Pete Lynch

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson

Heather Armstrong

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUGGMUPGURR
Date   Source Headline
10th Dec 202112:10 pmRNSResult of Placing and Subscription
9th Dec 20216:28 pmRNSClose of Bookbuild and Subscription
9th Dec 202112:30 pmRNSProposed Equity Raise
1st Dec 20217:00 amRNSCollaboration on Air and Water Filtration
29th Nov 20217:00 amRNSGrant Award for Industrial Filtration
24th Nov 20217:00 amRNSAward of Green Economy Mark
16th Nov 20217:00 amRNSDirectorate Change
11th Nov 20217:00 amRNSCompany Excellence Awards 2021 - Rising Star Award
1st Nov 20217:00 amRNSLaunch of High Performance Trail Running Shoes
14th Oct 20217:00 amRNSAdditional Italian Government Covid Recovery Loan
11th Oct 20217:00 amRNSInvestor Presentation
7th Oct 20217:00 amRNSReactivation of Decontamination Contract
29th Sep 20217:00 amRNSHalf-year Report
8th Sep 20217:00 amRNSMilan Design Week Showcases New G+ Coatings
9th Aug 20217:00 amRNSEU Grant Award
2nd Aug 20217:00 amRNSItalian Government Covid-19 Recovery Loans
28th Jul 20219:12 amRNSSignificant Tender Win
27th Jul 20217:00 amRNSSilver Medal Win in Shirt Printed by Directa
12th Jul 20217:00 amRNSPublication of peer reviewed scientific paper
23rd Jun 20215:19 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
17th Jun 20213:47 pmRNSAward of Options
7th Jun 20212:05 pmRNSSecond Price Monitoring Extn
7th Jun 20212:00 pmRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSNexTech Batteries Partnership Progresses
26th May 20215:20 pmRNSNotice of AGM
17th May 20217:00 amRNSFinal Results for the Year to 31 December 2020
5th May 20217:00 amRNSGrant of EU Production Process Patent
27th Apr 20217:00 amRNSImproved textile printing with graphene inks
19th Apr 20217:00 amRNSNew Safety Test
9th Apr 20217:00 amRNSAppointment of CFO
29th Mar 20217:00 amRNSEurope-wide Patent Granted for G+ in Golf Balls
18th Mar 20217:00 amRNSTrading Update
9th Mar 20217:00 amRNSSuccessful Absorption Evaluation Test
22nd Feb 20217:00 amRNSSupply and R&D Agreements with NexTech Batteries
10th Feb 202111:05 amRNSSecond Price Monitoring Extn
10th Feb 202111:00 amRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSFlame retardant properties of G+ established
3rd Feb 20217:00 amRNSEU grant to enhance Covid resistant face-masks
29th Jan 20219:05 amRNSSecond Price Monitoring Extn
29th Jan 20219:00 amRNSPrice Monitoring Extension
28th Jan 20214:40 pmRNSSecond Price Monitoring Extn
28th Jan 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSAddition to Decontamination and Recovery Contract
21st Jan 20217:00 amRNSDirectorate Change
15th Jan 20217:00 amRNSExercise of Options and Director / PDMR Dealing
11th Jan 20219:06 amRNSSecond Price Monitoring Extn
11th Jan 20219:00 amRNSPrice Monitoring Extension
11th Jan 20217:00 amRNSTrading Update
3rd Dec 20207:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.